Surabgene Lomparvovec Clinical Trials (2026): 2 Studies for Diabetic Retinopathy & Neovascular Age-related Macular Degeneration
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
2 Surabgene Lomparvovec clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Diabetic Retinopathy & Neovascular Age-related Macular Degeneration) and 1,137 total planned enrollment. 1 Phase 3 Surabgene Lomparvovec trial are listed. 2 Surabgene Lomparvovec clinical trials are actively recruiting at 51 U.S. sites across 20 states. Most recent activity: NCT07592273 (Jan 2036).
Where to Participate: All Surabgene Lomparvovec Trial Sites in the U.S. (51 sites across 20 states)
Every actively recruiting Surabgene Lomparvovectrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AZ | Barnet Dulaney Perkins Eye Centers /ID# 279265 | Mesa85206 | NCT07007065 | Map |
| AZ | American Vision Partners /ID# 264615 | Sun City85351 | NCT07007065 | Map |
| CA | Retinal Diagnostic Center /ID# 263054 | Campbell95008 | NCT07007065 | Map |
| CA | The Retina Partners /ID# 263265 | Encino91436 | NCT07007065 | Map |
| CA | Retina Associates of Southern California /ID# 263056 | Huntington Beach92647 | NCT07007065 | Map |
| CA | Northern California Retina Vitreous Associates - Mountain View /ID# 263990 | Mountain View94040-4119 | NCT07007065 | Map |
| CA | Northern California Retina Vitreous Associates /ID# 282994 | Mountain View94040-4119 | NCT07592273 | Map |
| CA | Retina Consultants of San Diego /ID# 264026 | Poway92064-2530 | NCT07007065 | Map |
| CA | Retina Consultants Of Southern California - Redlands /ID# 276496 | Redlands92374 | NCT07007065 | Map |
| CA | Kaiser Permanente - Riverside Medical Center /ID# 263253 | Riverside92505 | NCT07007065 | Map |
| CA | Retinal Consultants - Sacramento - Greenback Lane /ID# 263983 | Sacramento95841 | NCT07007065 | Map |
| CA | UCSF, Wayne and Gladys Valley Center for Vision /ID# 263058 | San Francisco94143-2510 | NCT07007065 | Map |
| CA | Orange County Retina Medical Group /ID# 266612 | Santa Ana92705 | NCT07007065 | Map |
| CO | Retina Consultants of Southern Colorado /ID# 263284 | Colorado Springs80909 | NCT07007065 | Map |
| CO | Colorado Retina Associates /ID# 263247 | Lakewood80228 | NCT07007065 | Map |
| CO | Advanced Vision Surgery Center /ID# 264208 | Longmont80503 | NCT07007065 | Map |
| FL | Advanced Research, LLC /ID# 276526 | Deerfield Beach33064-1346 | NCT07007065 | Map |
| FL | Retina Vitreous Consultants LLP business DBA as Retina Group of Florida /ID# 264631 | Fort Myers33917 | NCT07007065 | Map |
| FL | Florida Retina Institute - Lake Mary /ID# 263288 | Lake Mary32746 | NCT07007065 | Map |
| FL | Florida Retina Consultants - Lakeland /ID# 275012 | Lakeland33805 | NCT07592273 | Map |
| FL | Center for Retina and Macular Disease /ID# 264201 | Winter Haven33880 | NCT07007065 | Map |
| GA | Southeast Retina Center /ID# 263264 | Augusta30909 | NCT07007065 | Map |
| IL | University Retina - Oak Forest /ID# 283021 | Oak Forest60452 | NCT07592273 | Map |
| IL | Springfield Clinic Main Campus /ID# 265202 | Springfield62703-2403 | NCT07007065 | Map |
| IN | Midwest Eye Institute North Indianapolis /ID# 264031 | Carmel46290 | NCT07007065 | Map |
| IA | Wolfe Eye Clinic - West Des Moines /ID# 263270 | West Des Moines50266 | NCT07007065 | Map |
| ME | Maine Eye Center - Marginal Way Campus /ID# 263251 | Portland04101 | NCT07007065 | Map |
| MD | The Retina Care Center /ID# 263263 | Baltimore21209 | NCT07007065 | Map |
| MD | Retina Specialist /ID# 264633 | Towson21204 | NCT07007065 | Map |
| MI | Associated Retinal Consultants /ID# 263289 | Royal Oak48073 | NCT07007065 | Map |
| MN | Retina Consultants of Minnesota (RCM) - Edina Retina Clinic /ID# 279427 | Edina55435 | NCT07007065 | Map |
| MN | Mayo Clinic - Minnesota /ID# 263977 | Rochester55905 | NCT07007065 | Map |
| MO | Retina Institute - St. Louis /ID# 263985 | St Louis63128 | NCT07007065 | Map |
| NV | Sierra Eye Associates /ID# 274737 | Reno89502 | NCT07592273 | Map |
| NJ | Monmouth Retina Consultants /ID# 279252 | Little Silver07739 | NCT07007065 | Map |
| OH | Cleveland Clinic - Cleveland /ID# 264210 | Cleveland44195 | NCT07007065 | Map |
| OH | Midwest Retina /ID# 263231 | Dublin43016 | NCT07007065 | Map |
| PA | Erie Retina Research /ID# 263287 | Erie16507 | NCT07007065 | Map |
| SC | Charleston Neuroscience Institute - Bluffton /ID# 264037 | Bluffton29910 | NCT07007065 | Map |
| SC | Charleston Neuroscience Institute - Charleston /ID# 276425 | Charleston29414 | NCT07007065 | Map |
| SC | Retina Consultants of South Carolina - Ladson /ID# 277596 | Ladson29456 | NCT07007065 | Map |
| SC | Retina Consultants of America /ID# 264038 | Mt. Pleasant29464 | NCT07007065 | Map |
| TX | Retina Research Institute of Texas /ID# 263233 | Abilene79606 | NCT07007065 | Map |
| TX | Austin Clinical Research, LLC /ID# 263229 | Austin78750-2298 | NCT07007065 | Map |
| TX | Austin Research Center for Retina /ID# 276101 | Austin78705 | NCT07592273 | Map |
| TX | Austin Retina Associates - Austin /ID# 266770 | Austin78705 | NCT07007065 | Map |
| TX | Star Retina /ID# 266386 | Burleson76028 | NCT07007065 | Map |
| TX | Retina Consultants of Texas /ID# 263274 | Houston77056-3030 | NCT07007065 | Map |
| TX | Austin Retina Associates - Round Rock /ID# 266776 | Round Rock78681 | NCT07007065 | Map |
| TX | Retina Consultants of Texas - Westover /ID# 264209 | San Antonio78251 | NCT07007065 | Map |
| UT | Rocky Mountain Retina Consultants /ID# 263266 | Murray84107 | NCT07007065 | Map |
Surabgene Lomparvovec clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P2/P3 | 1 | 1 |
| P3 | 1 | 1 |
Recruiting Surabgene Lomparvovec clinical trials (2)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07592273 | NAAVIGATESurabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema | P2/P3 | Diabetic Retinopathy | 576 | Jun 2026 |
| NCT07007065 | Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) | P3 | Neovascular Age-related Macular Degeneration | 561 | Nov 2025 |
Surabgene Lomparvovec clinical trials by indication
Diabetic Retinopathy (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07592273 | NAAVIGATE | P2/P3 | recruiting | Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema |
Neovascular Age-related Macular Degeneration (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07007065 | — | P3 | recruiting | Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) |
All Surabgene Lomparvovec trials (2)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07592273 | NAAVIGATE | Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema | P2/P3 | recruiting | 576 | AbbVie | Jun 2026 |
| NCT07007065 | Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) | P3 | recruiting | 561 | AbbVie | Nov 2025 |
Surabgene Lomparvovec clinical trials: frequently asked questions
- How many Surabgene Lomparvovec clinical trials are there?
- 2 Surabgene Lomparvovec clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants.
- Are Surabgene Lomparvovec clinical trials recruiting in 2026?
- Yes — 2 Surabgene Lomparvovec trials are actively recruiting in 2026, with 51 U.S. sites across 20 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is Surabgene Lomparvovec being studied for?
- Surabgene Lomparvovec is being studied for Diabetic Retinopathy, Neovascular Age-related Macular Degeneration. The trials are grouped by indication on this page.
- What phase is Surabgene Lomparvovec in?
- Surabgene Lomparvovec clinical trials span 1 Phase 3. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Surabgene Lomparvovec clinical trials?
- The lead sponsor across the most Surabgene Lomparvovec trials is AbbVie. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Surabgene Lomparvovecas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: